InQpharm Europe Limited – Trademark Portfolio
Entity Type: 16
InQpharm Europe Limited holds 27 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 23 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 6 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include REDUSURE and XALUDICIN. The owner is based in HITCHIN, HERTFORDSHIRE.
WILBURY WAY
INVISION HOUSE
HITCHIN, HERTFORDSHIRE SG40TY , GB
Showing of trademarks Trademarks
Trademark Classifications
InQpharm Europe Limited's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does InQpharm Europe Limited have?
InQpharm Europe Limited has 27 U.S. trademarks filed with the USPTO. Of these, 2 registered, 6 abandoned, 19 cancelled.
What trademark classes does InQpharm Europe Limited file in?
InQpharm Europe Limited files trademarks across 6 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products), Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are InQpharm Europe Limited's most well-known trademarks?
InQpharm Europe Limited's registered trademark portfolio includes well-known marks such as REDUSURE and XALUDICIN. These are among 2 currently registered trademarks in the portfolio.
What is InQpharm Europe Limited's trademark registration success rate?
InQpharm Europe Limited has a 7% trademark registration rate, with 2 out of 27 resolved applications resulting in successful registration. Currently, 0 applications are pending review.